We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

CELLAVISION AB

CellaVision AB provides digital solutions for medical microscopy in the field of hematology, with its product portfol... read more Featured Products: More products

Download Mobile App




Atypical Chronic Lymphocytic Leukemia Identified by Digital Microscopy

By LabMedica International staff writers
Posted on 09 Sep 2014
Print article
Image: Photomicrograph of a blood film from a patient with atypical chronic lymphocytic leukemia. Lymphocytes were primarily small with round nuclei, condensed chromatin and scant cytoplasm. Approximately 20% of the lymphocytes had the morphologic features of prolymphocytes with finely dispersed chromatin and central nucleoli (arrows) (Photo courtesy of the American Society of Hematology).
Image: Photomicrograph of a blood film from a patient with atypical chronic lymphocytic leukemia. Lymphocytes were primarily small with round nuclei, condensed chromatin and scant cytoplasm. Approximately 20% of the lymphocytes had the morphologic features of prolymphocytes with finely dispersed chromatin and central nucleoli (arrows) (Photo courtesy of the American Society of Hematology).
Digital microscopy has been used to morphologically classify chronic lymphocytic leukemia (CLL) patients as atypical chronic lymphocytic leukemia (aCLL) or typical CLL (tCLL), and determine the prevalence of prognostic markers in each group.

In tCLL, which are approximately 80% of all cases, over 90% of the circulating lymphocytes are small-to-medium sized with relatively normal morphology, except for a characteristically clumped, chunky chromatin pattern.

Scientists at the Memorial Sloan Kettering Cancer Center (New York, NY, USA) evaluated the lymphocyte morphology on archived blood films of 97 CLL patients, and results of their prognostic marker analysis at diagnosis were obtained between January 2010 and December 2011. All patients included had a confirmed diagnosis of CLL; availability of results for complete blood count, immunophenotyping, immunoglobulin heavy chain V-III region VH26 (IgVH) mutation status, and fluorescence in situ hybridization (FISH) for trisomy 12 and deletions of 13q14, 6q, 17p (tumor protein 53, TP53), and 11q (ataxia telangiectasia mutated, ATM); and an archived peripheral blood film. The age of the archived blood films varied between 8 and 26 months.

The archived Romanowsky-stained blood films were reexamined using the Cellavision AB digital imaging system (Lund, Sweden). Additional lymphocyte subtypes were created within Cellavision for manual subclassification of variant forms seen in aCLL including prolymphocyte, large atypical lymphocyte, and cleaved lymphocyte. The team found that 27% of patients with CLL in their study were morphologically classified as aCLL, similar to that reported in the literature. The aCLL group had a higher prevalence of trisomy 12, unmutated IgVH, and cluster of differentiation 38 (CD38) expression markers associated with poor prognosis.

The authors concluded that using digital microscopy to morphologically identify lymphocyte subtypes and sub classify patients with CLL as tCLL or aCLL is a feasible, rapid, and inexpensive screening tool. Stable morphology consistent with tCLL over time may eliminate the need for more frequent and expensive genetic monitoring, while an unexpected change in morphologic sub classification from tCLL to aCLL may trigger a more extensive workup and a change in therapeutic approach. The study was published in the August 2014 issue of the International Journal of Laboratory Hematology.

Related Links:

Memorial Sloan Kettering Cancer Center
Cellavision AB 


Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit
New
Dermatophytosis Rapid Diagnostic Kit
StrongStep Dermatophytosis Diagnostic Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.